Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies

M G Larach1, H Rosenberg, G A Gronert

  • 1Hahnemann School of Medicine, USA.

Clinical Pediatrics
|January 1, 1997
PubMed

Insights

Pediatric cardiac arrests linked to succinylcholine anesthesia may indicate undiagnosed myopathy. Early screening for occult myopathy and modified life support protocols to manage hyperkalemia can improve survival rates in children.

Area of Science:

  • Anesthesiology
  • Pediatric Critical Care
  • Neuromuscular Disorders

Background:

  • Reports of cardiac arrest in children receiving succinylcholine prompted investigation into anesthesia-related pediatric arrests.
  • Malignant Hyperthermia Association of the United States and The North American Malignant Hyperthermia Registry data from 1990-1993 were analyzed.

Purpose of the Study:

  • To analyze the etiology of reported pediatric anesthesia-related arrests.
  • To determine if patient or treatment variables were associated with survival following arrest.

Main Methods:

  • Retrospective review of pediatric (age < 18 years) arrests within 24 hours of anesthesia.
  • Determination of arrest etiology and presence of myopathy.
  • Analysis of serum potassium levels, resuscitation duration, and patient outcomes.

Main Results:

  • Twenty-five pediatric patients arrested, 92% male, median age 45 months, mostly undergoing minor surgery.
  • Hyperkalemia was detected in 72% of patients with measured serum potassium.
  • Occult myopathy, including Duchenne dystrophy, was diagnosed in 48% of patients; 40% had no postarrest evaluation for myopathy.

Conclusions:

  • Pediatricians should screen for occult myopathy, especially in male infants and children, before surgery.
  • Pediatric advanced life support protocols need modification to detect and treat hyperkalemia during resuscitations.
  • Preanesthetic creatine kinase screening and succinylcholine restrictions could potentially prevent a majority of arrests and deaths.

Related Concept Videos

Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...